false
0000946563
0000946563
2024-05-10
2024-05-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported) |
May 10, 2024 |
Retractable
Technologies, Inc.
(Exact name of registrant
as specified in its charter)
Texas |
001-16465 |
75-2599762 |
(State or other jurisdiction |
(Commission |
(IRS Employer |
of incorporation) |
File Number) |
Identification No.) |
511
Lobo Lane, Little
Elm, Texas |
75068-5295 |
(Address of principal executive
offices) |
(Zip Code) |
Registrant's
telephone number, including area code |
(972)
294-1010 |
None
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
Common
Stock |
RVP |
NYSE
American |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging
growth company ¨ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.07 - Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Shareholders
of Retractable Technologies, Inc. was held as a virtual meeting on May 10, 2024. Abstentions are considered present for purposes
of calculating the vote but are not considered to have been voted in favor of the matters voted upon and broker non-votes are not considered
present for purposes of calculating the votes.
The final voting results
are as follows:
The Election of Three Class 2 Directors
All Directors nominated by
the Board of Directors were elected. Voting results are shown in the table below.
| |
Votes For | | |
Votes Withheld | | |
Abstentions
and Broker
Non-Votes | |
CLASS 2 DIRECTORS | |
| | | |
| | | |
| | |
Thomas J. Shaw | |
| 19,813,088 | | |
| 865,410 | | |
| 0 | |
Walter O. Bigby, Jr. | |
| 19,085,632 | | |
| 1,592,866 | | |
| 0 | |
John W. Fort III | |
| 19,718,001 | | |
| 960,497 | | |
| 0 | |
On May 15, 2024, the
Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing results for the quarter
ended March 31, 2024.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
104 |
Cover Page Interactive Date File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DATE: May 15, 2024 |
RETRACTABLE
TECHNOLOGIES, INC. |
|
(Registrant) |
|
|
|
|
BY: |
/s/ JOHN W.
FORT III |
|
|
JOHN W. FORT III |
|
|
VICE PRESIDENT, CHIEF FINANCIAL
OFFICER, AND
CHIEF ACCOUNTING OFFICER |
Exhibit 99
RETRACTABLE TECHNOLOGIES, INC. RESULTS
FOR THE PERIOD ENDED MARCH 31, 2024
LITTLE
ELM, TEXAS, May 15, 2024 — Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million
for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the
same period last year of $11.0 million and an operating loss of $2.7 million. The differences in the revenues and operating losses are
largely due to the lack of syringe sales to the international market for COVID-19 vaccination efforts in the first quarter of 2024 as
compared to a high volume of such sales in the first quarter of 2023. Operating expenses decreased 12.9% as compared to the prior
year due in part to a significant reduction in property tax expense as a result of newly enacted legislation. Unrealized gains on investments
were a significant factor in the computation of net income for the first quarter of 2024. Retractable reports that domestic demand may
be depressed due to the retention of products previously provided for vaccination purposes in customers’ inventory.
Retractable’s Form 10-Q filed on May 15,
2024 additionally reports that a new 50% tariff on syringes and needles will likely take effect in the third quarter of 2024. As
Retractable purchased over 90% of its products from China in the first quarter of 2024, most of which would likely be subject to the newly
announced tariffs, the new tariffs are a significant risk factor.
Retractable experienced significant growth in
late 2020 through early 2022 due to material orders from the U.S. government to supply syringes for COVID-19 vaccination efforts. Such
orders included payment for certain freight charges as well. As a result, comparability to revenues and expenses in recent years may be
challenging. Below are first quarter revenue figures from 2018 – 2024, as obtained from Retractable’s Quarterly Reports on
Form 10-Q as filed with the U.S Securities and Exchange Commission.
| |
Three
Months Ended March 31, | |
(Amounts
in millions) | |
2024 | | |
2023 | | |
2022 | | |
2021 | | |
2020 | | |
2019 | | |
2018 | |
U.S. sales (excluding
U.S. government) | |
$ | 6.6 | | |
$ | 5.4 | | |
$ | 10.2 | | |
$ | 11.0 | | |
$ | 8.3 | | |
$ | 6.1 | | |
$ | 6.6 | |
Sales to U.S. government | |
| — | | |
| — | | |
| 15.7 | | |
| 37.8 | | |
| — | | |
| — | | |
| — | |
North and South America sales
(excluding U.S.) | |
| 0.2 | | |
| 4.8 | | |
| 11.1 | | |
| 0.9 | | |
| 2.8 | | |
| 1.3 | | |
| 1.0 | |
Other
international sales | |
| 0.8 | | |
| 0.8 | | |
| 7.7 | | |
| 0.4 | | |
| 0.1 | | |
| 0.5 | | |
| 0.1 | |
Total
sales | |
$ | 7.6 | | |
$ | 11.0 | | |
$ | 44.7 | | |
$ | 50.1 | | |
$ | 11.2 | | |
$ | 7.9 | | |
$ | 7.7 | |
Retractable reports the following results of operations
for the three months ended March 31, 2024 and 2023, respectively. Further details concerning the results of operations, as well as
other matters, are available in Retractable’s Form 10-Q filed on May 15, 2024 with the U.S Securities and Exchange Commission.
Comparison of Three Months Ended March 31,
2024 and March 31, 2023
Domestic sales accounted for 87.4% and 49.3% of
the revenues for the three months ended March 31, 2024 and 2023, respectively. Domestic revenues increased 22.5%. Domestic
unit sales increased 18.3%. Domestic unit sales were 86.1% of total unit sales for the three months ended March 31, 2024.
International revenues decreased approximately 82.8% predominately due to fewer international vaccination-related sales. Overall
unit sales decreased 48.2%. There is uncertainty as to the timing of future international orders.
Cost of manufactured product decreased 31.4% principally
due to decreased unit sales. Royalty expense decreased 15.6% due to the associated decrease in gross sales.
Operating expenses decreased 12.9% from the prior
year. This is substantially due to a reduction of expense associated with the allowance for anticipated credit losses and a reduction
of property tax expense as a result of newly enacted property tax exemption legislation relating to medical device property.
The loss from operations was nearly $3.0 million
as compared to a loss of $2.7 million for the same period last year. The increased loss was due to lower gross profit for the current
period, offset by a reduction in overall operating expenses.
The unrealized gain on debt and equity securities
was $1.7 million due to the increased market values of those securities.
The
provision for income taxes was $86 thousand for the first quarter of 2024 as compared to a provision for income taxes of $231 thousand
for the first quarter of 2023.
ABOUT RETRACTABLE
Retractable manufactures and markets VanishPoint®
and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe,
blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly
from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed
to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable
needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint®
needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general
line distributors.
For
more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release
are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current
views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.
However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from
such statements.
Factors that could cause or contribute to such
differences include, but are not limited to: material changes in demand, potential tariffs, Retractable's ability to maintain liquidity;
Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements
and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players
in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic
reports filed with the U.S. Securities and Exchange Commission.
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and Chief Accounting Officer
v3.24.1.1.u2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Retractable Technologies (AMEX:RVP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Retractable Technologies (AMEX:RVP)
Historical Stock Chart
From Oct 2023 to Oct 2024